187 related articles for article (PubMed ID: 19148484)
1. Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas.
Juhlin CC; Haglund F; Villablanca A; Forsberg L; Sandelin K; Bränström R; Larsson C; Höög A
Int J Oncol; 2009 Feb; 34(2):481-92. PubMed ID: 19148484
[TBL] [Abstract][Full Text] [Related]
2. Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas.
Juhlin CC; Nilsson IL; Johansson K; Haglund F; Villablanca A; Höög A; Larsson C
Endocr Pathol; 2010 Sep; 21(3):166-77. PubMed ID: 20473645
[TBL] [Abstract][Full Text] [Related]
3. Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?
Cetani F; Ambrogini E; Viacava P; Pardi E; Fanelli G; Naccarato AG; Borsari S; Lemmi M; Berti P; Miccoli P; Pinchera A; Marcocci C
Eur J Endocrinol; 2007 May; 156(5):547-54. PubMed ID: 17468190
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomas.
Obrador-Hevia A; Chin SF; González S; Rees J; Vilardell F; Greenson JK; Cordero D; Moreno V; Caldas C; Capellá G
J Pathol; 2010 May; 221(1):57-67. PubMed ID: 20196079
[TBL] [Abstract][Full Text] [Related]
5. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
6. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis.
Chetty R; Serra S; Salahshor S; Alsaad K; Shih W; Blaszyk H; Woodgett JR; Tsao MS
Hum Pathol; 2006 Feb; 37(2):212-7. PubMed ID: 16426922
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas.
Wang ZK; Liu J; Liu C; Wang FY; Chen CY; Zhang XH
J Gastroenterol Hepatol; 2012 Oct; 27(10):1629-34. PubMed ID: 22741528
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes.
Andreasson A; Sulaiman L; do Vale S; Martins JM; Ferreira F; Miltenberger-Miltenyi G; Batista L; Haglund F; Björck E; Nilsson IL; Höög A; Larsson C; Juhlin CC
Fam Cancer; 2012 Sep; 11(3):355-62. PubMed ID: 22395475
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Wnt target genes in adenomas of familial adenomatous polyposis patients.
D'Orazio D; Muller PY; Heinimann K; Albrecht C; Bendik I; Herzog U; Tondelli P; Bauerfeind P; Müller H; Dobbie Z
Anticancer Res; 2002; 22(6A):3409-14. PubMed ID: 12530096
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
[TBL] [Abstract][Full Text] [Related]
11. Parafibromin, APC, and MIB-1 Are Useful Markers for Distinguishing Parathyroid Carcinomas From Adenomas.
Hosny Mohammed K; Siddiqui MT; Willis BC; Zaharieva Tsvetkova D; Mohamed A; Patel S; Sharma J; Weber C; Cohen C
Appl Immunohistochem Mol Morphol; 2017; 25(10):731-735. PubMed ID: 27490759
[TBL] [Abstract][Full Text] [Related]
12. Familial adenomatous polyposis associated with multiple endocrine neoplasia type 1-related tumors and thyroid carcinoma: a case report with clinicopathologic and molecular analyses.
Sakai Y; Koizumi K; Sugitani I; Nakagawa K; Arai M; Utsunomiya J; Muto T; Fujita R; Kato Y
Am J Surg Pathol; 2002 Jan; 26(1):103-10. PubMed ID: 11756777
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas.
Cetani F; Pardi E; Banti C; Collecchi P; Viacava P; Borsari S; Fanelli G; Naccarato AG; Saponaro F; Berti P; Miccoli P; Pinchera A; Marcocci C
Endocr Relat Cancer; 2010 Mar; 17(1):1-6. PubMed ID: 19755524
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma.
Howell VM; Gill A; Clarkson A; Nelson AE; Dunne R; Delbridge LW; Robinson BG; Teh BT; Gimm O; Marsh DJ
J Clin Endocrinol Metab; 2009 Feb; 94(2):434-41. PubMed ID: 19017757
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
[TBL] [Abstract][Full Text] [Related]
16. Adenomatous polyposis coli (Apc) tumor suppressor gene as a multifunctional gene.
Senda T; Shimomura A; Iizuka-Kogo A
Anat Sci Int; 2005 Sep; 80(3):121-31. PubMed ID: 16158975
[TBL] [Abstract][Full Text] [Related]
17. Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.
Starker LF; Fonseca AL; Akerström G; Björklund P; Westin G; Carling T
Endocrine; 2012 Dec; 42(3):612-5. PubMed ID: 22576020
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical and molecular features of sporadic and FAP-associated duodenal adenomas of the ampullary and nonampullary mucosa.
Wagner PL; Chen YT; Yantiss RK
Am J Surg Pathol; 2008 Sep; 32(9):1388-95. PubMed ID: 18670349
[TBL] [Abstract][Full Text] [Related]
19. Loss of beta-catenin expression in metastatic gastric cancer.
Ebert MP; Yu J; Hoffmann J; Rocco A; Röcken C; Kahmann S; Müller O; Korc M; Sung JJ; Malfertheiner P
J Clin Oncol; 2003 May; 21(9):1708-14. PubMed ID: 12721245
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implication.
Kastritis E; Murray S; Kyriakou F; Horti M; Tamvakis N; Kavantzas N; Patsouris ES; Noni A; Legaki S; Dimopoulos MA; Bamias A
Int J Cancer; 2009 Jan; 124(1):103-8. PubMed ID: 18844223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
